Learn R Programming

twang (version 1.3-14)

lindner: Lindner Center data on 996 PCI patients analyzed by Kereiakes et al. (2000)

Description

These data are adapted from the lindner dataset in the USPS package. The description comes from that package, except for the variable sixMonthSurvive, which is a recode of lifepres Data from an observational study of 996 patients receiving an initial Percutaneous Coronary Intervention (PCI) at Ohio Heart Health, Christ Hospital, Cincinnati in 1997 and followed for at least 6 months by the staff of the Lindner Center. The patients thought to be more severely diseased were assigned to treatment with abciximab (an expensive, high-molecular-weight IIb/IIIa cascade blocker); in fact, only 298 (29.9 percent) of patients received usual-care-alone with their initial PCI.

Usage

data(lindner)

Arguments

References

Kereiakes DJ, Obenchain RL, Barber BL, et al. Abciximab provides cost effective survival advantage in high volume interventional practice. Am Heart J 2000; 140: 603-610.

Obenchain RL. (2009) USPSinR.pdf ../R_HOME/library/USPS 40 pages.